Owonikoko TK - Search Results

1

Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials.

Chen Z, Cui Y, Owonikoko TK, Wang Z, Li Z, Luo R, Kutner M, Khuri FR, Kowalski J. Chen Z, et al. Among authors: owonikoko tk. Contemp Clin Trials. 2014 Mar;37(2):322-32. doi: 10.1016/j.cct.2014.02.004. Epub 2014 Feb 12. Contemp Clin Trials. 2014. PMID: 24530487 Free PMC article.

2

Preoperative therapy for early-stage NSCLC: opportunities and challenges.

Owonikoko TK, Khuri FR, Ramalingam SS. Owonikoko TK, et al. Oncology (Williston Park). 2009 Sep;23(10):886, 889, 892. Oncology (Williston Park). 2009. PMID: 19839430 Free article. No abstract available.

3

Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer.

Ramalingam SS, Harvey RD, Saba N, Owonikoko TK, Kauh J, Shin DM, Sun SY, Strychor S, Tighiouart M, Egorin MJ, Fu H, Khuri FR. Ramalingam SS, et al. Among authors: owonikoko tk. Cancer. 2010 Aug 15;116(16):3903-9. doi: 10.1002/cncr.25264. Cancer. 2010. PMID: 20564143 Free PMC article. Clinical Trial.

4

Lung cancer in the elderly: what's age got to do with it?

Owonikoko TK, Ramalingam SS, Khuri FR. Owonikoko TK, et al. Oncology (Williston Park). 2010 Nov 15;24(12):1120, 1122, 1129. Oncology (Williston Park). 2010. PMID: 21141693 No abstract available.

5

Lung cancer: New biological insights and recent therapeutic advances.

Ramalingam SS, Owonikoko TK, Khuri FR. Ramalingam SS, et al. Among authors: owonikoko tk. CA Cancer J Clin. 2011 Mar-Apr;61(2):91-112. doi: 10.3322/caac.20102. Epub 2011 Feb 8. CA Cancer J Clin. 2011. PMID: 21303969 Free article.

6

Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.

Li C, Fan S, Owonikoko TK, Khuri FR, Sun SY, Li R. Li C, et al. Among authors: owonikoko tk. Oncogene. 2011 Sep 1;30(35):3802-12. doi: 10.1038/onc.2011.94. Epub 2011 Apr 11. Oncogene. 2011. PMID: 21478903 Free PMC article.

7

The combination of RAD001 and NVP-BEZ235 exerts synergistic anticancer activity against non-small cell lung cancer in vitro and in vivo.

Xu CX, Li Y, Yue P, Owonikoko TK, Ramalingam SS, Khuri FR, Sun SY. Xu CX, et al. Among authors: owonikoko tk. PLoS One. 2011;6(6):e20899. doi: 10.1371/journal.pone.0020899. Epub 2011 Jun 14. PLoS One. 2011. PMID: 21695126 Free PMC article.

8

Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.

Pakkala S, Chen Z, Rimland D, Owonikoko TK, Gunthel C, Brandes JR, Saba NR, Shin DM, Curran WJ Jr, Khuri FR, Ramalingam SS. Pakkala S, et al. Among authors: owonikoko tk. Cancer. 2012 Jan 1;118(1):164-72. doi: 10.1002/cncr.26242. Epub 2011 Jun 28. Cancer. 2012. PMID: 21713759 Free PMC article.

9

Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy.

Xu CX, Zhao L, Yue P, Fang G, Tao H, Owonikoko TK, Ramalingam SS, Khuri FR, Sun SY. Xu CX, et al. Among authors: owonikoko tk. Cancer Biol Ther. 2011 Sep 15;12(6):549-55. doi: 10.4161/cbt.12.6.16397. Epub 2011 Sep 15. Cancer Biol Ther. 2011. PMID: 21738008 Free PMC article.

10

What is the role of maintenance therapy in the treatment of non-small cell lung cancer?

Jiang Y, Owonikoko TK, Ramalingam SS, Khuri FR, Belani CP. Jiang Y, et al. Among authors: owonikoko tk. Ther Adv Med Oncol. 2010 Jul;2(4):229-35. doi: 10.1177/1758834010368045. Ther Adv Med Oncol. 2010. PMID: 21789136 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters